Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 12 | 2024 | 1038 | 2.340 |
Why?
|
| Thrombolytic Therapy | 7 | 2024 | 251 | 1.970 |
Why?
|
| Brain Ischemia | 5 | 2023 | 405 | 1.530 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2022 | 174 | 1.510 |
Why?
|
| Fibrinolytic Agents | 5 | 2024 | 233 | 1.200 |
Why?
|
| Thrombectomy | 6 | 2024 | 197 | 1.010 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 110 | 0.660 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 159 | 0.650 |
Why?
|
| Ischemic Attack, Transient | 1 | 2021 | 186 | 0.640 |
Why?
|
| Cerebral Hemorrhage | 2 | 2019 | 360 | 0.530 |
Why?
|
| Informed Consent | 1 | 2018 | 278 | 0.470 |
Why?
|
| Emergency Medical Services | 3 | 2021 | 248 | 0.440 |
Why?
|
| Hospitals | 1 | 2017 | 314 | 0.440 |
Why?
|
| Endovascular Procedures | 3 | 2024 | 309 | 0.370 |
Why?
|
| Patient Transfer | 2 | 2021 | 103 | 0.340 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2729 | 0.320 |
Why?
|
| Biomarkers | 1 | 2016 | 1850 | 0.320 |
Why?
|
| Time-to-Treatment | 2 | 2021 | 130 | 0.310 |
Why?
|
| Chicago | 5 | 2021 | 1466 | 0.230 |
Why?
|
| Treatment Outcome | 7 | 2024 | 8740 | 0.230 |
Why?
|
| Humans | 19 | 2024 | 92337 | 0.220 |
Why?
|
| Retrospective Studies | 7 | 2024 | 9703 | 0.210 |
Why?
|
| Carotid Arteries | 1 | 2024 | 134 | 0.210 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2023 | 63 | 0.200 |
Why?
|
| Female | 11 | 2024 | 47893 | 0.190 |
Why?
|
| Rehabilitation Centers | 1 | 2021 | 8 | 0.190 |
Why?
|
| Stents | 1 | 2024 | 417 | 0.190 |
Why?
|
| Allied Health Personnel | 1 | 2021 | 20 | 0.180 |
Why?
|
| Embolization, Therapeutic | 1 | 2024 | 260 | 0.180 |
Why?
|
| Research Report | 1 | 2021 | 44 | 0.180 |
Why?
|
| Stroke Rehabilitation | 1 | 2021 | 43 | 0.180 |
Why?
|
| Natural Language Processing | 1 | 2021 | 43 | 0.170 |
Why?
|
| Triage | 1 | 2021 | 125 | 0.170 |
Why?
|
| Male | 11 | 2024 | 43925 | 0.170 |
Why?
|
| Risk Factors | 3 | 2020 | 5704 | 0.160 |
Why?
|
| Hemostatics | 1 | 2019 | 59 | 0.160 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 807 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 996 | 0.150 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 152 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2021 | 443 | 0.140 |
Why?
|
| Recurrence | 1 | 2020 | 1180 | 0.140 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1733 | 0.140 |
Why?
|
| Aged | 7 | 2024 | 19943 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2019 | 473 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 559 | 0.120 |
Why?
|
| Lipids | 1 | 2016 | 278 | 0.110 |
Why?
|
| Catheters | 2 | 2024 | 85 | 0.110 |
Why?
|
| Middle Aged | 7 | 2024 | 27030 | 0.110 |
Why?
|
| Lung | 1 | 2020 | 1337 | 0.110 |
Why?
|
| Pregnancy | 1 | 2020 | 3110 | 0.100 |
Why?
|
| Hospitalization | 1 | 2018 | 927 | 0.100 |
Why?
|
| Registries | 1 | 2018 | 902 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 27532 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2023 | 6916 | 0.080 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2009 | 22 | 0.080 |
Why?
|
| Raphe Nuclei | 1 | 2009 | 37 | 0.080 |
Why?
|
| Cardiovascular System | 1 | 2009 | 64 | 0.080 |
Why?
|
| Respiratory System | 1 | 2009 | 119 | 0.080 |
Why?
|
| Morphine | 1 | 2009 | 130 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3509 | 0.070 |
Why?
|
| Time Factors | 3 | 2021 | 5430 | 0.070 |
Why?
|
| United States | 1 | 2018 | 7348 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2009 | 472 | 0.060 |
Why?
|
| Radial Artery | 1 | 2024 | 36 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2024 | 156 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 130 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2024 | 444 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2021 | 35 | 0.050 |
Why?
|
| Neurosurgical Procedures | 1 | 2024 | 312 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 490 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2680 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2019 | 37 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2019 | 129 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 868 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 337 | 0.040 |
Why?
|
| Delirium | 1 | 2018 | 73 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2018 | 186 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2019 | 295 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 785 | 0.030 |
Why?
|
| Seizures | 1 | 2018 | 312 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1239 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1592 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2009 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 2352 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 377 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2369 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 492 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2978 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 4468 | 0.020 |
Why?
|
| Adolescent | 1 | 2023 | 9504 | 0.020 |
Why?
|
| Arrhythmia, Sinus | 1 | 2009 | 7 | 0.020 |
Why?
|
| Microinjections | 1 | 2009 | 71 | 0.020 |
Why?
|
| Bradycardia | 1 | 2009 | 42 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2018 | 2458 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2009 | 183 | 0.020 |
Why?
|
| Motor Activity | 1 | 2009 | 330 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 502 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 450 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1235 | 0.020 |
Why?
|
| Sleep | 1 | 2009 | 461 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 4067 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2448 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 3360 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 12110 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 28003 | 0.010 |
Why?
|